Literature DB >> 25499079

Pancreatic cancer stem cells: new insight into a stubborn disease.

Han-xiang Zhan1, Jian-wei Xu1, Dong Wu1, Tai-ping Zhang2, San-yuan Hu3.   

Abstract

Resistance to conventional therapy and early distant metastasis contribute to the unsatisfactory prognosis of patients with pancreatic cancer. The concept of cancer stem cells (CSCs) brings new insights into cancer biology and therapy. Many studies have confirmed the important role of these stem cells in carcinogenesis and the development of hematopoietic and solid cancers. Recent studies have shown that CSCs regulate aggressive behavior, recurrence, and drug resistance in pancreatic cancer. Here, we review recent advances in pancreatic cancer stem cells (PCSCs) research. Particular attention is paid to the regulation mechanisms of pancreatic cancer stem cell functions, such as stemness-related signaling pathways, microRNAs, the epithelial-mesenchymal transition (EMT), and the tumor microenvironment, and the development of novel PCSCs targeted therapy. We seek to further understand PCSCs and explore potential therapeutic targets for pancreatic cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Chemotherapy resistance; Metastasis; Pancreatic cancer; microRNA

Mesh:

Substances:

Year:  2014        PMID: 25499079     DOI: 10.1016/j.canlet.2014.12.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

1.  A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm).

Authors:  Anna Sanchez Calle; Neha Nair; Aung KoKo Oo; Marta Prieto-Vila; Megumi Koga; Apriliana Cahya Khayrani; Maram Hussein; Laura Hurley; Arun Vaidyanath; Akimasa Seno; Yoshiaki Iwasaki; Malu Calle; Tomonari Kasai; Masaharu Seno
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas.

Authors:  Francesca Boscolo Sesillo; Alessandra Sacco
Journal:  J Vis Exp       Date:  2019-09-13       Impact factor: 1.355

Review 3.  miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.

Authors:  Anteneh A Tesfaye; Asfar S Azmi; Philip A Philip
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

Review 4.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 5.  Gastric cancer stem cells: evidence, potential markers, and clinical implications.

Authors:  Daniel Brungs; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Martin G Carolan; Marie Ranson
Journal:  J Gastroenterol       Date:  2015-10-01       Impact factor: 7.527

Review 6.  Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer.

Authors:  Fan Lei; Xinyuan Xi; Surinder K Batra; Tatiana K Bronich
Journal:  J Pharmacol Exp Ther       Date:  2019-02-22       Impact factor: 4.030

Review 7.  How does the tumor microenvironment play a role in hepatobiliary tumors?

Authors:  Fathima Kamil; Julie H Rowe
Journal:  J Gastrointest Oncol       Date:  2018-02

Review 8.  Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters.

Authors:  Patricia Dauer; Alice Nomura; Ashok Saluja; Sulagna Banerjee
Journal:  Pancreatology       Date:  2016-12-23       Impact factor: 3.996

9.  The identification and validation of Trichosstatin A as a potential inhibitor of colon tumorigenesis and colon cancer stem-like cells.

Authors:  Tse-Hung Huang; Szu-Yuan Wu; Yan-Jiun Huang; Po-Li Wei; Alexander Th Wu; Tsu-Yi Chao
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 10.  Concise Review: Pancreatic Cancer and Bone Marrow-Derived Stem Cells.

Authors:  Wojciech Błogowski; Tomasz Bodnarczuk; Teresa Starzyńska
Journal:  Stem Cells Transl Med       Date:  2016-05-23       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.